In another study, despite the increased serum levels of IL-4 in NZB/NZW mice that reflected Th2 activation in vivo, treatment with statins was not associated with a significant improvement in clinical and laboratory parameters of SLE disease activity including proteinuria, serum anti-dsDNA antibody levels and survival [93]. Here, IL4 is linked to systemic lupus erythematosus.